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O ptimizing growth and develop-ment from conception to child-
hood through good nutrition, a clean
environment, and adequate holistic
health care is essential for the improve-
ment of health and economic develop-
ment of populations.1,2 Throughout this
critical period, growth, which is a
continuous process, must be monitored
routinely with the use of congruent
screening tools and criteria. Focusing
conceptually on only 1 speciﬁc phase or a
single summary value (eg, late fetal
growth or estimated fetal weight) has
limited biologic basis and lessens the
chances for timely and appropriate
interventions.
Growth monitoring (GM) is an inte-
gral and undisputed component of
evidence-based antenatal and newborn
care worldwide, as it is for infants and
children. However, to be effective, GM
requires a comprehensive set of anthro-
pometric standards that enable skeletal
growth (eg, fetal head circumference or
postnatal length) and fat-related markers
(eg, fetal abdominal circumference or
postnatal weight) to be assessed longi-
tudinally so that judgments can be made
about the appropriateness of growth
patterns and deviations (eg, whether the
fetus/newborn/infant is wasted, stunted,
or overweight/obese).3 These tools have
been available to evaluate term infants’
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A comprehensive set of fully integrated anthropometric measures is needed to evaluate
human growth from conception to infancy so that consistent judgments can be made
about the appropriateness of fetal and infant growth. At present, there are 2 barriers to
this strategy. First, descriptive reference charts, which are derived from local, unse-
lected samples with inadequate methods and poor characterization of their putatively
healthy populations, commonly are used rather than prescriptive standards. The use of
prescriptive standards is justified by the extensive biologic, genetic, and epidemiologic
evidence that skeletal growth is similar from conception to childhood across geographic
populations, when health, nutrition, environmental, and health care needs are met.
Second, clinicians currently screen fetuses, newborn infants, and infants at all levels of
care with a wide range of charts and cutoff points, often with limited appreciation of the
underlying population or quality of the study that generated the charts. Adding to the
confusion, infants are evaluated after birth with a single prescriptive tool: the World
Health Organization Child Growth Standards, which were derived from healthy, breastfed
newborn infants, infants, and young children from populations that have been exposed
to few growth-restricting factors. The International Fetal and Newborn Growth Con-
sortium for the 21st Century Project addressed these issues by providing international
standards for gestational age estimation, first-trimester fetal size, fetal growth, newborn
size for gestational age, and postnatal growth of preterm infants, all of which com-
plement the World Health Organization Child Growth Standards conceptually, meth-
odologically, and analytically. Hence, growth and development can now, for the first
time, be monitored globally across the vital first 1000 days and all the way to 5 years of
age. It is clear that an integrative approach to monitoring growth and development from
pregnancy to school age is desirable, scientifically supported, and likely to improve care,
referral patterns, and reporting systems. Such integration can be achieved only through
the use of international growth standards, especially in increasingly diverse, mixed
ancestry populations. Resistance to new scientific developments has been hugely
problematic in medicine; however, we are confident that the obstetric and neonatal
communities will join their pediatric colleagues worldwide in the adoption of this inte-
grative strategy.
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postnatal growth, but not fetal growth,
newborn size, or the postnatal growth of
preterm newborn infants.
Two barriers thwart the implementa-
tion of the missing perinatal component
of the GM strategy. First, unlike in most
other ﬁelds of medicine, descriptive
reference charts, rather than prescriptive
standards, are used in obstetric and
neonatal practice. Standards are prefer-
able because they describe aspirational,
biologic norms that are achieved by
healthy populations and individuals
throughout the world. References, on the
other hand, describe the distribution of
variables that are observed in unselected
samples at a given time and place, often
decades ago.4 They provide information
that is of limited value today for clini-
cians, parents, and families because the
criteria used to select subjects and deﬁne
their health were often ill-deﬁned. This
applies, for example, to the Hadlock
charts of estimated fetal weight, which
are presently used worldwide, evaluated
in 109 fetuses from a hospital in Texas
in the 1980s.5
The second barrier is the large num-
ber and limited methodologic quality
of the charts that are available to obste-
tricians and neonatologists. In a series
of systematic reviews, we showed that
there are (1) 29 published charts for
estimating gestational age that use crown
rump length, of which only 4 satisﬁed
minimum quality criteria6; (2) 83 pub-
lished fetal size charts for monitoring
growth by ultrasound scanning, of which
only 12 used a reliable dating method7;
(3) 102 published charts of birthweight
for gestational age, of which only 8
satisﬁed minimum quality criteria,8 and
(4) 61 published postnatal growth charts
for preterm infants with considerable
shortcomings in the quality of anthro-
pometric evaluation, gestational age
estimation, length of follow-up evalua-
tion, and reportage of postnatal care,
feeding regimes, and morbidities. In
addition, the choice of a particular
reference chart is too often based on
clinicians’ preferences or on the default
chart offered in the ultrasound ma-
chine’s software, which can lead to
different references being used even
within the same medical practice. Fi-
nally, there is considerable variability
in the deﬁnition of intrauterine growth
restriction (IUGR) with the use of
combinations of ultrasound measures.
Consequently, clinicians currently
monitor fetuses and newborn infants at
different levels of care and institutions
with a wide range of charts. Variable cut-
off points (3rd, 5th, 10th, 90th, 95th,
or 97th percentiles) are used to deﬁne
“normality,” macrosomia, and IUGR.
Often there is little appreciation of the
underlying population or quality of the
study that generated the chart being
used. Consequently, fetuses can be clas-
siﬁed as growth-restricted or overgrown
in 1 part of a city or country and as
healthy in another. For example, Salo-
mon et al9 showed that the proportion
of fetuses who were classiﬁed as having
a biparietal diameter below the 5th
percentile at 20-24 weeks of gestation
can range from 6.6e23.7% with the
use of 3 different popular ultrasound
reference charts. More confusing still is
that, only 1 month after birth, infants
are evaluated by pediatricians with the
use of a single, prescriptive tool, the
World Health Organization (WHO)
Child Growth Standards, that was derived
from healthy newborn infants from
populations with few growth-restricting
factors whose mothers followed breast-
feeding recomendations.10 This situation
must result inevitably in diagnostic inac-
curacies, confusion for parents, and
inappropriate interventions.
In an era of evidence-based medi-
cine, supporting an approach in which
different tools and criteria are used
depending on whether the babies are
inside the womb, newly born, or aged1
month is difﬁcult to justify scientiﬁcally
and to parents. The fact that the WHO
Child Growth Standards have been
adopted in >125 countries, including
the United States, United Kingdom, and
Norway,11 demonstrates that standardi-
zation of care is feasible and acceptable
across vastly different countries and
medical systems.
The International Fetal and Newborn
Growth Consortium for the 21st Cen-
tury (INTERGROWTH-21st) Project
has produced an integrated set of stan-
dards for gestational age estimation,12
ﬁrst-trimester fetal size,12 fetal growth13
(to be supported by fetal growth veloc-
ity and estimated fetal weight standards
in 2016), newborn size for gestational
age,14 postnatal growth of preterm in-
fants,15 and, in 2016, infant development
at 2 years old.16 The percentiles of the
INTERGROWTH-21st newborn stan-
dards are remarkably similar at term to
those of the WHO Child Growth Stan-
dards (Figure 1), which is not surprising
because the 2 studies adopted the same
conceptual, methodologic, and analytic
approaches. This means that growth and
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development, for the ﬁrst time, can be
monitored with the same high-quality
tools across the vital ﬁrst 1000 days and
up to the age of 5 years.
The INTERGROWTH-21st standards
were developed from a prospective,
population-based project that selected
8 urban areas across 5 continents. Most
inhabitants were healthy, adequately
nourished, and educated with minimal
environmental constraints on growth.17
Within each of these study sites, in a
second sampling step, pregnant women
at low risk of IUGR were recruited.18
All of them had a reliable estimate of
gestational age conﬁrmed by ultrasound
scanning. The same, specially adapted,
ultrasound equipment was used at all
sites to allow blinding of measurements.
A novel quality-control strategy, which
included centralized image storage,
enabled the independent review of im-
ages and measurements.19,20 Newborn
infants were measured with the same
methods and quality control protocols as
in the WHO Child Growth Standards
Study21 with a follow-up study of their
growth, diet, morbidity, and cognitive
development16 until 2 years of age from
which a functional classiﬁcation of IUGR
and macrosomia will be generated.
Reassuringly, the growth and develop-
ment at 1 year of age of term and preterm
newborn infants closely match the
WHO Child Growth Standards.13,15
Although we have presented our curves
with commonly used statistical cutoffs
(eg, 3rd and 97th percentiles), as is the
case for infant and child growth stan-
dards,10 we presently are conducting
analyses to identify which cutoff points
best predict perinatal and postnatal
outcomes14 for incorporation in an
evidence-based triage for global peri-
natal care.
It could be argued that the observed
geographic and ethnic variations in fetal
growth across populations preclude the
use of international standards. These
arguments are difﬁcult to support, given
the widespread use in medicine of uni-
versal deﬁnitions based on data that are
FIGURE 1
INTERGROWTH-21st Newborn Standards complementing the WHO Child
Growth Standards
A B
The 3rd, 50th, and 97th percentile curves for birthweight according to gestational age and sex
(A, boys; B, girls) from the INTERGROWTH-21st Newborn Size Standards14 (red lines) followed by
the corresponding 3rd, 50th, and 97th percentile curves from the World Health Organization
Child Growth Standards for term (40 weeks of gestation) newborn infants according to sex.9
WHO-MGRS, World Health Organization Child Growth Standards.
Villar. Monitoring human growth and development. Am J Obstet Gynecol 2015.
TABLE
Variance component analysis for fetal newborn infant and child skeletal growth and size
Variable
Fetal ultrasound scan, %
Birth:
newborn22
Infancy: preterm
infant length15
Infancy and
childhood:
infant length10
Childhood:
child height23
Fetal crown-rump
length22
Fetal head
circumference22
Variance between
study sites, %
1.9 2.6 3.5 0.2 3.4 3.0
Variance between
individuals within
a site, %
— 18.6 — 57.1 70.0 —
Residual variance, % 98.1 78.8 96.5 42.7 26.6 —
Variance between individuals for these measures cannot be estimated because they were taken from cross-sectional data.
Villar. Monitoring human growth and development. Am J Obstet Gynecol 2015.
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obtained from healthy subjects and
their use for comparisons across pop-
ulations. As an example, no one suggests
that the deﬁnition of anemia should
be altered locally for malnourished
populations; in fact, international com-
parisons regarding the prevalence of
anemia would be impossible without
universally accepted hemoglobin cutoff
points.
GM of the fetus, neonate, and child
up to 5 years old should be done in the
same way. International standards are
justiﬁed by the evidence that skeletal
and linear growth in humans is similar
from conception to childhood across
geographic populations, when health,
nutrition, and health care needs are met.
These data demonstrate that only <4%
of the total variability in growth and size
during pregnancy, at birth, during in-
fancy, and childhood can be attributed
to differences between populations,
as opposed to variability among in-
dividuals within the same population
(Table).10,22,23
The alternative (ie, the use of local
charts based on unselected samples) in-
volves major clinical and public health
risks. First, if fetuses and newborn in-
fants are evaluated in such a manner,
the rate of IUGR or small-for-gestational
age <10th percentile, by deﬁnition,
will be close to 10% in all populations,
regardless of the local prevalence of
malnutrition or morbidity, which is
FIGURE 2
Sensitivity analyses of the populations in the INTERGROWTH-21st Project
A
B
CA and B, Crown rump length and fetal head
circumference 3rd, 50th, and 97th percentiles
for the total Fetal Growth Longitudinal Study
population (solid line); the remaining sample
after data from the sites in China, India, Kenya,
and the UK were excluded one at a time. C, Birth
length at 3rd, 50th, and 97th percentiles for the
low-risk proportion of the total Newborn Cross-
Sectional Study population (solid line), and the
remaining sample after data from the sites in
China, India, Kenya, and the UK were excluded
one at a time. A detailed description of the
studies and analytic strategy is available in
the article by Villar et al.22
Reproduced, with permission, from Villar J et al.22
Villar. Monitoring human growth and development. Am J
Obstet Gynecol 2015.
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epidemiologically implausible. For
example, recently it was estimated that
the prevalence of small-for-gestational
age in low-to-middle income countries
is at least 24%24 and the prevalence of
stunting in these countries ranges from
10e40%,2 which is in keeping with the
corresponding rates of stillbirth and
neonatal, infant, and <5-year morbidity
and mortality.25
At the other end of the spectrum,
whenever local unselected populations
in developed regions are used as their
own reference, overweight newborn in-
fants are considered “normal” (ie, their
early obesity is not diagnosed). This
occurs because many countries and
subpopulations, in the midst of the
childhood obesity and diabetes mellitus
epidemics,26 have shifted their percen-
tiles upwards to include bigger babies.
For example, in England in 2011-2012
the rate of birthweight >90th percentile
was 11% using local references but 19%
using international standards.27 Only by
using a single set of international
newborn size standards14 can the 2 sit-
uations described earlier be avoided.
Another argument against the use of
the international newborn size standards
is the variability that is observed between
the highest and lowest birthweights in
the populations that are used for their
construction. Clearly, some variability
exists even in the healthy populations
included in the INTERGROWTH-21st
Project, but such a comparison is not
relevant to the question of whether to
use international growth standards. It
was never suggested nor recommended
that data from a single country should be
used to evaluate another population or
vice versa. The question is not how a
single population of fetuses or newborn
babies compares in length or weight with
another population such as the United
Kingdom’s. The question, instead, is how
each of these compares with the inter-
national standards that were constructed
with all populations combined. Sensi-
tivity analyses demonstrated that the
exclusion of any of the populations in the
WHO Child Growth Standards Study
or INTERGROWTH-21st Project had
negligible effect on the pooled values
from all the study sites and that the
percentiles were indistinguishable when
superimposed (Figure 2).22
Furthermore, recommending that
growth charts should be ethnic/racial-
speciﬁc, based on the concept that
certain ethnic or racial groups have a
genetic predisposition to small or large
size at birth, has no scientiﬁc basis in
nonisolated populations. First, ethnicity
and race are social, not biologic, con-
structs. As a Nature Biotechnology 2005
editorial concluded: “Scientiﬁcally, race
is a meaningless marker of anything.
Pooling people in race silos is akin to
zoologists grouping raccoons, tigers and
okapis on the basis that they are all stri-
pey.”28 These are not even well-deﬁned
terms: a systematic review identiﬁed
116 deﬁnitions of self-reported race or
ethnicity in the medical literature.29
Second, most populations have been
subjected to marked genetic admixture,
including the United States,30 such that
>6 million North Americans, who self-
identify as European, probably carry
African ancestry.31 Third, nearly 700
genetic variants have been implicated in
adult height (compared with the few
associated with skin pigmentation), but
even these only explain one-ﬁfth of the
heritability of height.32 The concept is
also contradicted by the overwhelming
literature that links physical growth in
humans to socioeconomic, environ-
mental, health, and nutrition conditions
worldwide.33 Hence, there is no scienti-
ﬁc basis for the adaption of fetal or
newborn growth charts based on the
self-reported ethnicity of the mother,
which is a procedure that makes even less
practical sense when we consider the
multiple permutations of mixed-
ethnicity couples and the extent of
present-day mass migration.
In summary, integrated monitoring
of growth and development from preg-
nancy to school age is desirable, scien-
tiﬁcally supported, and likely both to
standardize and improve health care and
referral patterns. Such integration can
be achieved only through the use of in-
ternational growth standards, especially
in increasingly diverse mixed ancestry
populations. These standards allow,
for the ﬁrst time, comparisons to be
made across populations from
conception onwards. They also greatly
facilitate our ability to address concerns
about fetal development and associated
health problems in later life by produc-
ing standardized global data instead of
the present paltry mishmash.
However, the implementation of the
standards requires giving consideration
to the resource implications, which
include the capacity of referral systems to
manage the number and severity of
identiﬁed cases (which depends on the
cutoff points selected) and the preva-
lence of risk factors. Operating within a
uniform system requires professional
adaptation and coordination across
levels of care. As never occurred when
the large number of currently used fetal
and neonatal charts were introduced, it
will be important to monitor how the
new standards are adopted and how
deviations from optimal growth are in-
terpreted. We are conﬁdent that, in
time, the INTERGROWTH-21st stan-
dards will be incorporated into care
and research34,35 just as the WHO Child
Growth Standards are used currently by
pediatricians worldwide.36 -
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